
Greater Washington has no shortage of respected leaders, and some of them are among the world’s most revered.

Greater Washington has no shortage of respected leaders, and some of them are among the world’s most revered.

Welcome to ARP Network Quarterly Notes! Our goal is to keep you informed about ARP Network and Agricultural Research Service’s current information. We hope that the notes build networking opportunities for businesses to connect with ARP Network Members. Please help us spread the word by sharing ARP Network Notes statewide with your company contacts, colleagues, other organizations, etc. Thank you!

What is Philips HealthWorks? As a venture capital fund, what qualities do you look for in a partner?
While the Philips HealthWorks team is linked to our Health Technology Venture Fund team at Philips, we see ourselves, first and foremost, as defining a new model for innovation community engagement. Think of Philips HealthWorks as a new front door for early-stage companies to collaborate with our global company.

The Emmes Corporation today announced that it is the new corporate sponsor of Leadership Montgomery’s Corporate Volunteer Council.
The grant from Emmes will help Leadership Montgomery add new business partners, help existing partners increase the number of employee volunteers, and match volunteer interests with the needs of area non-profit and charitable organizations.

Institute for Bioscience & Biotechnology Research 9600 Gudelsky Drive Rockville, MD, Maryland 20850
Wednesday, October 4, 2017 from 6:00 PM to 8:00 PM (EDT)
As physicians, scientists and entrepreneurs, sometimes we believe that we can do it all, only to find out that our attempts at practicing law, accounting or financial strategy are many times misguided. Come and learn from experts in the field about the obstacles and opportunities that are ahead of you and how best to navigate these choppy waters!

CEL-SCI Corporation (NYSE American: CVM) announced today that it has been awarded a new Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases entitled “Preclinical studies of PG70 LEAPS peptide vaccine for rheumatoid arthritis”. The grant in the amount of approximately $1.5 million will provide funding to allow CEL-SCI to advance its first LEAPS product candidate, CEL-4000, towards an Investigational New Drug (IND) application, by funding GMP manufacturing, IND enabling studies, and additional mechanism of action studies.

Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes magazine’s special centennial issue, released today, as one of The World’s 100 Greatest Living Business Minds. In celebration of its 100th anniversary, Forbes magazine’s collector’s edition features essays, lessons and ideas for the next 100 years from today’s most influential business leaders around the world.

When a hospital needs to rush a delivery from a lab somewhere else in a densely populated city–for example, when a surgeon needs an urgent biopsy of a tumor in the middle of a surgery to determine how much tissue to remove, or a gunshot victim in the ER needs blood that the hospital doesn’t have in stock–that delivery can sometimes get stuck in traffic. Couriers are also expensive. In Switzerland, hospitals and labs will soon begin using drones to make those deliveries instead.

When: Tuesday, October 17, 2017 from 5:00 PM to 7:00 PM EDT
Where: 7 Locks Brewing 12227 Wilkins Avenue Rockville, MD 20852
Join BioBuzz along with Double Helix Sponsor CRB and event sponsor ISPE-CBA as we visit 7 Locks Brewing in Rockville for this special networking event. The Science of Beer was created when we learned that many scientists and bbrewers. This is our opportunity to bring our members and brewing professionals together to network and sample some of the tastiest beers. This event has a limit on registration. please don’t sign-up unless you are certain to attend!

Start here. That all-encompassing theme reverberated across Johns Hopkins Technology Ventures’ efforts to bring the benefits of discovery to the world in fiscal year 2017.